Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 3 ( July-September, 2024 ) > List of Articles

Original Article

Prevalence of Comorbidities in Obstructive Sleep Apnea and Association with Disease Severity: A Descriptive Study

Priyadarshini M, Mandeep K Sodhi, Chahat Bhatia, Shivani Jaswal, Deepak Aggarwal, Varinder Saini

Keywords : Comorbidities, Hypertension, Obesity, Obstructive sleep apnea

Citation Information : M P, Sodhi MK, Bhatia C, Jaswal S, Aggarwal D, Saini V. Prevalence of Comorbidities in Obstructive Sleep Apnea and Association with Disease Severity: A Descriptive Study. Indian J Respir Care 2024; 13 (3):152-157.

DOI: 10.5005/jp-journals-11010-1120

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background and objectives: Obstructive sleep apnea (OSA) is being progressively encountered in clinical practice due to the mounting epidemic of obesity, owing to an upsurge in sedentary habits in rural and urban populations. Sleep-related disorders are a common cause of morbidity and can lead to wide range of potentially fatal health problems such as high blood pressure, obesity, hypercholesterolemia, diabetes, heart attacks, and depression. The current study was steered with the objective to estimate the prevalence of comorbidities in patients with OSA and to evaluate the association between comorbidities and severity of OSA. Materials and methods: Sixty patients with OSA were included in the current study, and the prevalence of comorbidities and their association with the severity of OSA were determined. Results: Out of 60 patients with OSA, 62% were males and 38% were females, and their mean apnea–hypopnea index (AHI) was 40.11 ± 25.78. Mild OSA was present in 15% of patients, moderate and severe OSA in 31.7 and 53.3%, respectively. Males had higher prevalence of severe OSA than females. The most prevalent comorbidities were obesity, which was seen in 70%, followed by hypertension in 63.3%, and depression in 56.7% of patients. Although these were more predominant in patients with severe OSA, the difference was not statistically significant. Conclusion: The present study concluded OSA as significant risk factor for the emergence of comorbidities. Hence, patients with symptoms suggestive of sleep apnea should be assessed and treated early because lack of awareness of the disease and its associated comorbidities may result in increased mortality.


PDF Share
  1. Zhang W, Si LY. Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches. Ups J Med Sci 2012;117:370–382. DOI: 10.3109/03009734.2012.707253
  2. Morselli LL, Guyon A, Spiegel K. Sleep and metabolic function. Pflugers Arch 2012;463:139–160. DOI: 10.1007/s00424-011-1053-z
  3. Singh A, Prasad R, Garg R, et al. A study to estimate prevalence and risk factors of obstructive sleep apnoea syndrome in a semi-urban Indian population. Monaldi Arch Chest Dis 2017;87:773. DOI: 10.4081/monaldi.2017.773
  4. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013–2016. DOI: 10.1001/jama.291.16.2013
  5. Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clinic Proc 2011;86:549−555. DOI: 10.4065/mcp.2010.0810
  6. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667–689. DOI: 10.1093/sleep/22.5.667
  7. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:479–504. DOI: 10.5664/jcsm.6506
  8. Carter R 3rd, Watenpaugh DE. Obesity and obstructive sleep apnea: or is it OSA and obesity? Pathophysiology 2008;15:71–77. DOI: 10.1016/j.pathophys.2008.04.009
  9. Lavie L. Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 2003;7:35–51. DOI: 10.1053/smrv.2002.0261
  10. Lévy P, Tamisier R, Minville C, et al. Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 2011;20:134–146. DOI: 10.1183/09059180.00003111
  11. Marrone O, Lo Bue A, Salvaggio A, et al. Comorbidities and survival in obstructive sleep apnoea beyond the age of 50. Eur J Clin Invest 2013;43:27–33. DOI: 10.1111/eci.12011
  12. Appleton SL, Gill TK, Lang CJ, et al. Prevalence and comorbidity of sleep conditions in Australian adults: 2016 Sleep Health Foundation national survey. Sleep Health 2018;4:13–19. DOI: 10.1016/j.sleh.2017.10.006
  13. Robichaud-Hallé L, Beaudry M, Fortin M. Obstructive sleep apnea and multimorbidity. BMC Pulm Med 2012;12:60. DOI: 10.1186/1471-2466-12-60
  14. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2010;33:11–61. DOI: 10.2337/dc10-S011
  15. Ahmad N, Adam SI, Nawi AM, et al. Abdominal obesity indicators: waist circumference or waist-to-hip ratio in Malaysian adults population. Int J Prev Med 2016;7:82. DOI: 10.4103/2008-7802.183654
  16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421. DOI: 10.1161/circ.106.25.3143
  17. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479–482. DOI: 10.1136/bmj.320.7233.479
  18. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018;36:1953–2041. DOI: 10.1097/HJH.0000000000001940
  19. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–613. DOI: 10.1046/j.1525-1497.2001.016009606.x
  20. Deng X, Gu W, Li Y, et al. Age-group-specific associations between the severity of obstructive sleep apnea and relevant risk factors in male and female patients. PLoS One 2014;9:e107380. DOI: 10.1371/journal.pone.0107380
  21. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003;42:1067–1074. DOI: 10.1161/01.HYP.0000101686.98973.A3
  22. Gilat H, Vinker S, Buda I, et al. Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study. Medicine (Baltimore) 2014;93:e45. DOI: 10.1097/MD.0000000000000045
  23. Prabakaran J, Bindu T. Correlation of BMI and neck circumference with severity of AHI in patients with obstructive sleep apnea. J Med Sci Clin Res 2019;7:822–825. DOI: 10.18535/jmscr/v7i1.143
  24. Pinto JA, Ribeiro DK, Cavallini AF, et al. Comorbidities associated with obstructive sleep apnea: a retrospective study. Int Arch Otorhinolaryngol 2016;20:145–150. DOI: 10.1055/s-0036-1579546
  25. Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension—an update. Hypertension 2014;63:203–209. DOI: 10.1161/HYPERTENSIONAHA.113.00613
  26. Ronksley PE, Hemmelgarn BR, Heitman SJ, et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009;64:834–839. DOI: 10.1136/thx.2009.115105
  27. Qian Y, Yi H, Zou J, et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea. Sci Rep 2016;6:26089. DOI: 10.1038/srep26089
  28. Tan KC, Chow WS, Lam JC, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377–382. DOI: 10.1016/j.atherosclerosis.2005.04.024
  29. Karkinski D, Georgievski O, Dzekova-Vidimliski P, et al. Obstructive sleep apnea and lipid abnormalities. Open Access Maced J Med Sci 2017;5:19–22. DOI: 10.3889/oamjms.2017.011
  30. Weiss JW, Remsburg S, Garpestad E, et al. Hemodynamic consequences of obstructive sleep apnea. Sleep 1996;19:388–397. DOI: 10.1093/sleep/19.5.388
  31. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–165. DOI: 10.1164/rccm.2105124
  32. Ejaz SM, Khawaja IS, Bhatia S, et al. Obstructive sleep apnea and depression: a review. Innov Clin Neurosci 2011;8:17–25. PMID: 21922066.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.